A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease

Keyphrases

• 25-hydroxyvitamin D (25OHD) 25%
• Advanced Fibrosis 25%
• Aggressive Therapy 25%
• Area under the ROC Curve 25%
• Cirrhosis 25%
• Clinical High Risk 50%
• Clinical Model 100%
• Combined Modality Therapy 25%
• Female Sex 25%
• Fibrosis 100%
• Fibrosis Score 50%
• Gamma-glutamyltransferase 75%
• High Parameter 25%
• Linear Regression 25%
• Liver Biopsy 100%
• Liver Fibrosis 50%
• Logistical Regression Model 25%
• Medical Encounter 25%
• Multivariate Logistic Regression 25%
• NAFLD Activity Score 25%
• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Non-invasive Parameters 50%
• Nonalcoholic Fatty Liver Disease Activity Score 25%
• Pediatric Patients 25%
• Pediatric Subjects 100%
• Platelet Count 25%
• Platelets 50%
• Poor Prognostic 25%
• Prediction Model 25%
• Prognostic Features 25%
• Rate Limiting 25%
• Scoring System 25%
• Shear Wave Velocity 25%
• Single Center 25%
• Ultrasound 25%
• Vitamin D 25%

Medicine and Dentistry

• Biopsy 80%
• Body Mass Index 20%
• Fibrosis 100%
• Gamma-Glutamyl Transpeptidase 60%
• Linear Regression Analysis 20%
• Liver Biopsy 100%
• Liver Cirrhosis 20%
• Liver Fibrosis 40%
• Logistic Regression Analysis 20%
• Non-Alcoholic Fatty Liver Disease 20%
• Nonalcoholic Fatty Liver 100%
• Nonalcoholic Fatty Liver Disease Activity Score 20%
• Pediatrics 100%
• Pediatrics Patient 20%
• Platelet 60%
• Scoring System 20%
• Sensitivity and Specificity 20%
• Vitamin D 40%